Revised SPC: Epidyolex (cannabidiol) 100 mg/ml oral solution

SPC has been updated to reflect the data of interaction studies involving rifampicin (GWEP17074), CYP1A2 substrate, caffeine (GWCP18056), stiripentol (GWEP1447) and of pharmacokinetic study GWEP17076, exploring the impact of meal, milk and alcohol on cannabidiol exposure.

electronic Medicines compendium